Chemoinformaics analysis of N-(3-METHYLBUT-2-EN-1-YL)-9H-PURIN-6-AMINE
| Molecular Weight | 203.249 | nRot | 3 |
| Heavy Atom Molecular Weight | 190.145 | nRig | 12 |
| Exact Molecular Weight | 203.117 | nRing | 2 |
| Solubility: LogS | -2.603 | nHRing | 2 |
| Solubility: LogP | 1.618 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 28 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 2 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 13 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 5 | No. of Arom Atom | 9 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 10 |
| nHA | 4 | APOL | 30.8683 |
| nHD | 2 | BPOL | 17.6017 |
| QED | 0.719 |
| Synth | 3.832 |
| Natural Product Likeliness | 0.648 |
| NR-PPAR-gamma | 0.028 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.998 |
| HIA | 0.007 |
| CACO-2 | -4.883 |
| MDCK | 0.00000408 |
| BBB | 0.507 |
| PPB | 0.651755 |
| VDSS | 1.085 |
| FU | 0.415407 |
| CYP1A2-inh | 0.8 |
| CYP1A2-sub | 0.159 |
| CYP2c19-inh | 0.287 |
| CYP2c19-sub | 0.062 |
| CYP2c9-inh | 0.022 |
| CYP2c9-sub | 0.349 |
| CYP2d6-inh | 0.779 |
| CYP2d6-sub | 0.023 |
| CYP3a4-inh | 0.22 |
| CYP3a4-sub | 0.496 |
| CL | 14.191 |
| T12 | 0.905 |
| hERG | 0.033 |
| Ames | 0.013 |
| ROA | 0.98 |
| SkinSen | 0.937 |
| Carcinogencity | 0.012 |
| EI | 0.891 |
| Respiratory | 0.976 |
| NR-Aromatase | 0.82 |
| Antiviral | No |
| Prediction | 0.645604 |